載入...
LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma
Neratinib is an orally available tyrosine kinase inhibitor targeting HER2 (ERBB2) and EGFR (ERBB). It is being clinically evaluated for the treatment of breast and other solid tumors types as a single agent or in combination with other chemotherapies. In support of several phase I/II clinical trials...
Na minha lista:
| 發表在: | J Pharm Biomed Anal |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5183482/ https://ncbi.nlm.nih.gov/pubmed/27907855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2016.11.035 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|